Xtant Medical Holdings Inc 2026年季度报告

FORM 10-Q (Mark One) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31, 2026 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934For the transition period from ________________ to __________________ Commission File Number: 001-34951 XTANT MEDICAL HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware20-5313323(State or other jurisdiction ofincorporation or organization)(I.R.S. EmployerIdentification No.) 664 Cruiser LaneBelgrade, Montana 59714(Address of principal executive offices) (Zip Code) (406) 388-0480(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon stock, par value $0.000001 per shareXTNTNYSE American LLC Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files). Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Accelerated filer☐Smaller reporting company☒Emerging growth company☐ Large accelerated filer☐Non-accelerated filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes☐No☒ As of May 8, 2026, there were 140,262,960 shares of common stock of the registrant outstanding. XTANT MEDICAL HOLDINGS, INC. FORM 10-QMarch 31, 2026 TABLE OF CONTENTS PageCAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTSiiPART I.FINANCIAL INFORMATION1ITEM 1.FINANCIAL STATEMENTS1ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OFOPERATIONS18ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK23ITEM 4.CONTROLS AND PROCEDURES23PART II.OTHER INFORMATION24ITEM 1.LEGAL PROCEEDINGS24ITEM 1A.RISK FACTORS24ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS24ITEM 3.DEFAULTS UPON SENIOR SECURITIES24ITEM 4.MINE SAFETY DISCLOSURES24ITEM 5.OTHER INFORMATION24ITEM 6.EXHIBITS25 This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safeharbor created by those sections. For more information, see “Cautionary Statement Regarding Forward-Looking Statements.” As used in this report, unless the context indicates another meaning, the terms “we,” “us,” “our,” “Xtant,” “Xtant Medical,”and the “Company” mean Xtant Medical Holdings, Inc. and its wholly owned subsidiaries, all of which are consolidated on Xtant’scondensed consolidated financial statements. All intercompany balances and transactions have been eliminated in consolidation. We own various unregistered trademarks and service marks, including our corporate logo. Solely for convenience, thetrademarks and trade names in this report are referred to without the ® and ™ symbols, but such references should not be construedas any indicator that the owner of such trademarks and trade names will not assert, to the fullest extent under applicable law, theirrights thereto. We do not intend the use or display of other companies’ trademarks and trade names to imply a relationship with, orendorsement or sponsorship of us by, any other companies. We include our website address throughout this report for reference only. The information contained on or connected to ourwebsite is not incorporated by reference into this report. CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking statementswithin the meaning of the Private Securities Litigation Reform Act of 1995. Our forward-looking statements include, but are notlimited to, stat